浙江四维医药科技有限公司

Zhejiang Siwei Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing services to global pharmaceutical firms for small molecule drug production. Its product portfolio covers various therapeutic areas, including cardiovascular, anti-infective, and metabolic diseases. Siwei Pharmaceutical maintains high-standard manufacturing facilities in the Zhejiang Provincial Chemical Specialized Zone that are compliant with international GMP regulations. The company is recognized for its expertise in complex chemical processes such as high-pressure hydrogenation and low-temperature reactions.